ASSESS-meso: a long-term study looking at people with mesothelioma (cancer of the outer lining of the lung) that will gather information on symptoms, disease processes and factors that affect survival
Not Applicable
- Conditions
- Mesothelioma (cancer of the outer lining of the lung)Cancer
- Registration Number
- ISRCTN61861764
- Lead Sponsor
- orth Bristol NHS Trust Research & Innovation Department
- Brief Summary
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36357003/ (added 11/11/2022) 2023 Interim results article in https://pubmed.ncbi.nlm.nih.gov/38174143/ Pre-specified interim analysis (baseline characteristics), conducted when recruitment reached 25% of target (added 08/01/2024)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
1. Histological, cytological or clinico-pathological diagnosis of mesothelioma, confirmed at MDT
2. Willing and able to comply with study follow up assessments (including at least 1 appointment at a study recruiting centre if identified at a PIC)
3. Has capacity, as defined by the 2005 Mental Capacity Act
Exclusion Criteria
1. Age < 18 years old
2. Unable to give written informed consent
3. Declines ongoing hospital follow up
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method